Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel in the Prevention of Severe SARS-CoV2 Pneumonia
NCT04445623Phase 3Unknown
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prasugrel in COVID-19 pneumonia, thrombosis, sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Status: unknown.
02
Drugs
prasugrel
03
Conditions
COVID-19 pneumoniathrombosis
Beyond the preview
Go deeper on NCT04445623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04445623.